Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Breath test screens for pulmonary embolisms:

This article was originally published in Clinica

Executive Summary

A bedside breath test that measures exhaled carbon dioxide levels could be used as a screening test for blood clots in the lungs of critically ill patients who have undergone surgery, a US team has found. The carbon dioxide expirogram, which may help some patients avoid undergoing a more invasive pulmonary angiography test, identified all five patients with pulmonary embolism and correctly identified eight of the nine patients who did not have a blood clot in their lungs, according to the study, published in the August edition of the Archives of Surgery. The test can be performed using equipment already available in hospitals.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079255

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel